Neuroone Medical Technologies (NMTC) EBIT Growth (1y) (2011 - 2026)
Neuroone Medical Technologies (NMTC) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -18.12% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 46.60% |
| 10 | Neuroone Medical Technologies | 29.19 Mn | 26.38 Mn | 1.29 Mn | 21.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.61% |
| Dec 31, 2025 | -199.77% |
| Sep 30, 2025 | 51.32% |
| Jun 30, 2025 | 32.47% |
| Mar 31, 2025 | 7.14% |
| Dec 31, 2024 | 150.47% |
| Sep 30, 2024 | 11.00% |
| Jun 30, 2024 | 20.41% |
| Mar 31, 2024 | 17.44% |
| Dec 31, 2023 | -90.01% |
| Sep 30, 2023 | -126.02% |
| Jun 30, 2023 | -27.12% |
| Mar 31, 2023 | -14.25% |
| Dec 31, 2022 | 36.48% |
| Sep 30, 2022 | 47.04% |
| Jun 30, 2022 | 9.01% |
| Mar 31, 2022 | -27.72% |
| Dec 31, 2021 | -31.07% |
| Sep 30, 2021 | -2,151.75% |
| Jun 30, 2021 | -90.46% |